281 related articles for article (PubMed ID: 35643530)
21. Lymph Node Metastasis and Extrathyroidal Extension in Papillary Thyroid Microcarcinoma in Cyprus: Suspicious Subcentimeter Nodules Should Undergo FNA When Multifocality is Suspected.
Papaioannou C; Lamnisos D; Kyriacou K; Lyssiotis T; Constantinides V; Frangos S; Economides A; Economides PA
J Thyroid Res; 2020; 2020():3567658. PubMed ID: 32351678
[TBL] [Abstract][Full Text] [Related]
22. Clinical impact of microscopic extrathyroidal extension in patients with papillary thyroid microcarcinoma treated with hemithyroidectomy.
Ahn D; Sohn JH; Jeon JH; Jeong JY
J Endocrinol Invest; 2014 Feb; 37(2):167-73. PubMed ID: 24497215
[TBL] [Abstract][Full Text] [Related]
23. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
[No Abstract] [Full Text] [Related]
24. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
[TBL] [Abstract][Full Text] [Related]
25. [Risk Factors of Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma:An Analysis Based on Data from the Surveillance, Epidemiology and End Results Database].
Zheng KS; Zeng Y; Chen C; Wu YZ; Chen B; Ying WB; Zheng KW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Dec; 40(6):736-743. PubMed ID: 30606382
[TBL] [Abstract][Full Text] [Related]
26. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two?
Arora N; Turbendian HK; Kato MA; Moo TA; Zarnegar R; Fahey TJ
Thyroid; 2009 May; 19(5):473-7. PubMed ID: 19348582
[TBL] [Abstract][Full Text] [Related]
27. Implications of Extrathyroidal Extension Invading Only the Strap Muscles in Papillary Thyroid Carcinomas.
Li G; Li R; Song L; Chen W; Jiang K; Tang H; Wei T; Li Z; Gong R; Lei J; Zhu J
Thyroid; 2020 Jan; 30(1):57-64. PubMed ID: 31830859
[No Abstract] [Full Text] [Related]
28. The contributing factors for lateral neck lymph node metastasis in papillary thyroid microcarcinoma (PTMC).
Kim K; Zheng X; Kim JK; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
Endocrine; 2020 Jul; 69(1):149-156. PubMed ID: 32146654
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Lobectomy and Total Thyroidectomy in Unilateral Papillary Thyroid Microcarcinoma Patients with Ipsilateral Lateral Lymph Node Metastasis Without Gross Extrathyroidal Extension.
Song J; Qiu W; Yan T; Wu B; Guo M; Fan Y; Yang Z
World J Surg; 2020 Aug; 44(8):2677-2684. PubMed ID: 32328782
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological Significance of Minimal Extrathyroid Extension in Solitary Papillary Thyroid Carcinomas.
Woo CG; Sung CO; Choi YM; Kim WG; Kim TY; Shong YK; Kim WB; Hong SJ; Song DE
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S728-33. PubMed ID: 26077913
[TBL] [Abstract][Full Text] [Related]
31. Gray-scale ultrasonography combined with elastography imaging for the evaluation of papillary thyroid microcarcinoma: as a prognostic clinicopathology factor.
Jin ZQ; Lin MY; Hu WH; Li WY; Bai SJ
Ultrasound Med Biol; 2014 Aug; 40(8):1769-77. PubMed ID: 24768485
[TBL] [Abstract][Full Text] [Related]
32. [Invasiveness of papillary thyroid microcarcinoma with BRAF mutation].
Yang X; Liang ZY; Meng C; Liang J; Yu Z; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):398-403. PubMed ID: 23987486
[TBL] [Abstract][Full Text] [Related]
33. Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma.
Siddiqui S; White MG; Antic T; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
Thyroid; 2016 Jun; 26(6):807-15. PubMed ID: 27117842
[TBL] [Abstract][Full Text] [Related]
34. Central lymph node metastasis is an important prognostic factor in patients with papillary thyroid microcarcinoma.
Lee J; Song Y; Soh EY
J Korean Med Sci; 2014 Jan; 29(1):48-52. PubMed ID: 24431905
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of extrathyroidal extension according to primary tumor size in papillary thyroid carcinoma.
Liu L; Oh C; Heo JH; Park HS; Lee K; Chang JW; Jung SN; Koo BS
Eur J Surg Oncol; 2018 Nov; 44(11):1754-1759. PubMed ID: 29934055
[TBL] [Abstract][Full Text] [Related]
36. Completion thyroidectomy may not be required for papillary thyroid carcinoma with multifocality, lymphovascular invasion, extrathyroidal extension to the strap muscles, or five or more central lymph node micrometastasis.
Beom Heo D; Piao Y; Hee Lee J; Ju SH; Yi HS; Su Kim M; Won HR; Won Chang J; Seok Koo B; Eun Kang Y
Oral Oncol; 2022 Nov; 134():106115. PubMed ID: 36108524
[TBL] [Abstract][Full Text] [Related]
37. Prediction of central lymph node metastasis in patientswith thyroid papillary microcarcinoma.
Akın Ş; Yazgan Aksoy D; Akın S; Kılıç M; Yetişir F; Bayraktar M
Turk J Med Sci; 2017 Dec; 47(6):1723-1727. PubMed ID: 29306230
[TBL] [Abstract][Full Text] [Related]
38. The appropriateness of thyroid lobectomy as an initial surgery for preoperatively detected unilateral multifocal papillary carcinoma.
Albinsaad LS; Kim WW; Lee YM; Sung TY; Chung KW; Hong SJ
Asian J Surg; 2021 Aug; 44(8):1050-1055. PubMed ID: 33573922
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of Papillary Thyroid Microcarcinoma Presenting with Palpable Lateral Lymphadenopathy.
Papachristos A; Do K; Tsang VH; Sywak M; Gill AJ; Sidhu S; Clifton-Bligh RJ; Glover A; Gild ML
Thyroid; 2022 Sep; 32(9):1086-1093. PubMed ID: 35703333
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]